SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-005411
Filing Date
2024-04-22
Accepted
2024-04-22 16:05:31
Documents
21
Period of Report
2024-04-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sngx-20240417x8k.htm   iXBRL 8-K 44599
2 EX-4.1 sngx-20240417xex4d1.htm EX-4.1 129989
3 EX-4.2 sngx-20240417xex4d2.htm EX-4.2 142597
4 EX-10.1 sngx-20240417xex10d1.htm EX-10.1 82571
5 EX-10.2 sngx-20240417xex10d2.htm EX-10.2 444961
6 EX-99.1 sngx-20240417xex99d1.htm EX-99.1 21964
7 GRAPHIC sngx-20240417xex99d1001.jpg GRAPHIC 14345
  Complete submission text file 0001558370-24-005411.txt   1180566

Data Files

Seq Description Document Type Size
8 EX-101.SCH sngx-20240417.xsd EX-101.SCH 4345
9 EX-101.DEF sngx-20240417_def.xml EX-101.DEF 3492
10 EX-101.LAB sngx-20240417_lab.xml EX-101.LAB 12255
11 EX-101.PRE sngx-20240417_pre.xml EX-101.PRE 10475
25 EXTRACTED XBRL INSTANCE DOCUMENT sngx-20240417x8k_htm.xml XML 4842
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14778 | Film No.: 24861196
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)